Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues	$ 0	$ 237,000	$ 0	$ 237,000
Operating Expenses:
Cost of revenues	0	200,326	0	200,326
General and administrative	335,326	363,209	1,603,869	858,455
Research and development	48,226	75,332	196,932	343,368
Depreciation and amortization	14,606	14,152	43,370	41,966
Total operating expenses	398,158	653,019	1,844,171	1,444,115
Loss from operations	(398,158)	(416,019)	(1,844,171)	(1,207,115)
Other income (expense):
Gain on remeasurement of warrant liability	54,982	0	284,651	0
Interest expense	(27,079)	(8,504)	(62,627)	(25,634)
Interest income	6	2	25	66
Net loss	(370,249)	(424,521)	(1,622,122)	(1,232,683)
Other comprehensive loss on foreign currency translation	(2,163)	(4,021)	(4,355)	(5,507)
Total comprehensive loss	$ (372,412)	$ (428,542)	$ (1,626,477)	$ (1,238,190)
Basic and diluted net loss per common share (in Dollars per share)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average number of common shares outstanding (in Shares)	401,673,199	371,151,459	398,041,211	370,333,703